Webinar: Building a Better Cell Therapy Potency Assay Through Multianalyte Profiling
Webinar Summary
Developing robust potency assays for CAR-T and CAR-NK cell therapies requires a more comprehensive understanding of immune cell function than can be achieved with traditional single-analyte measurements alone. This webinar explores a multianalyte strategy that combines broad biomarker discovery with automated protein quantification to identify, verify, and measure the biomarkers that best reflect effector cell potency.
Using data generated from CD19 CAR-T and CD19 CAR-NK cells across multiple donors, you'll see how this workflow supports the development of standardized, multianalyte potency assays that provide a more representative assessment of immune cell function while improving reproducibility and assay standardization.
What You'll Learn
- How broad multiplex biomarker discovery can be used to identify functional biomarkers for CAR-T and CAR-NK cell potency.
- Why multianalyte protein signatures provide a more representative assessment of effector cell potency than traditional single-analyte measurements.
- How to transition from broad biomarker discovery to targeted, multianalyte potency assays using a streamlined, standardized workflow.
- How automated multianalyte protein quantification can improve assay reproducibility, standardization, and scalability for cell therapy research.